Oxyvet 300 LA (Canada)

Oxytetracycline (as Dihydrate) Sterile Injectable Solution

Veterinary Use Only

Antibiotic

DIN 02339935

Description

OXYVET 300 LA injectable solution, is specially formulated to provide sustained antibiotic blood levels up to 4 days in cattle and pigs following a single treatment.

OXYVET 300 LA injectable solution is a sterile, long acting stable aqueous solution containing oxytetracycline dihydrate equivalent to 300 mg oxytetracycline base per mL.

OXYVET 300 LA injectable solution combines broad spectrum effectiveness against both gram positive and gram negative bacteria, with prolonged antibiotic blood levels up to 4 days duration following a single treatment.

Oxyvet 300 LA Indications

OXYVET 300 LA injectable solution is indicated in the treatment of all infections caused by oxytetracycline susceptible bacteria in cattle and pigs.

CATTLE: Bacterial pneumonia, Pasteurellosis (associated with shipping fever complex), Mastitis, Metritis, Calf Scours (bacterial enteritis), Foot Rot, Navel ill, Calf Diphtheria, Leptospirosis, Blackleg/Malignant Edema, Peritonitis, Joint ill.

SWINE: Erysipelas, Bacterial enteritis, Leptospirosis, Metritis, Mastitis, Bacterial pneumonia.

Dosage and Administration

For intramuscular or subcutaneous administration to cattle and intramuscular administration to pigs at a single dose rate of 1 mL per 15 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

It is recommended that the maximum dose at any one site is 10 mL in cattle and 5 mL in pigs to minimize local tissue irritation at the injection site. Intramuscular injections should be made deep into the fleshy part of the muscle such as the neck. Subcutaneous injections should be administered in the neck region.

Following administration, temporary localised swelling may be observed at the site of injection for several days. This is due to the high concentration and long acting effect of the product.

OXYVET 300 LA injectable solution should be warmed to body temperature prior to administration.

If clinical improvement is not observed after 48 hours, clinical re-evaluation may be required. In non-responsive cases, consideration may be given to the use of an alternative antibiotic.

Note: Treatment with OXYVET 300 LA only, in severe disease cases, may be insufficient.

Cautions:

Occasional hypersensitivity reactions (anaphylaxis) have been observed following the parenteral administration of oxytetracycline. If such side effects occur, discontinue use of the drug and administer epinephrine immediately. The safety of this product in pregnant animals has not been demonstrated.

Warnings

Intramuscular administration:

Treated animals must not be slaughtered for use in food for at least 21 days after the latest treatment with this drug. Do not use in lactating dairy cattle.

Subcutaneous administration:

Treated cattle must not be slaughtered for use in food for at least 42 days after the latest treatment with this drug. Do not use in lactating dairy cattle.

Keep out of reach of children.

Note: To avoid the possibility of excessive trim at the site of injection, do not slaughter cattle for at least 42 days after the latest treatment with this drug.

Storage

Store between 15°C and 25°C. Protect from light. Do not freeze.

Presentation:

OXYVET 300 LA injectable solution is available in multidose 500 mL vials.

Manufactured by:

Norbrook Laboratories Limited, Newry, BT35 6JP, Northern Ireland

Distributed by:

Vetoquinol N.-A. Inc., 2000, ch. Georges, Lavaltrie, QC, Canada J5T 3S5

^® Registered trademark of Vetoquinol N.-A. Inc.

CONTAINS ANTIMICROBIAL

USE RESPONSIBLY

CPN: 1234475.0